IL135349A0 - Statin-carboxyalkylether combinations - Google Patents

Statin-carboxyalkylether combinations

Info

Publication number
IL135349A0
IL135349A0 IL13534998A IL13534998A IL135349A0 IL 135349 A0 IL135349 A0 IL 135349A0 IL 13534998 A IL13534998 A IL 13534998A IL 13534998 A IL13534998 A IL 13534998A IL 135349 A0 IL135349 A0 IL 135349A0
Authority
IL
Israel
Prior art keywords
carboxyalkylether
statin
combinations
carboxyalkylether combinations
Prior art date
Application number
IL13534998A
Other languages
English (en)
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Priority to IL15659198A priority Critical patent/IL156591A0/xx
Priority to IL15732498A priority patent/IL157324A0/xx
Priority to IL15732398A priority patent/IL157323A0/xx
Priority to IL15732598A priority patent/IL157325A0/xx
Publication of IL135349A0 publication Critical patent/IL135349A0/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365Lactones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404Indoles, e.g. pindolol
    • A61K31/405Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
IL13534998A 1997-12-12 1998-11-20 Statin-carboxyalkylether combinations IL135349A0 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
IL15659198A IL156591A0 (en) 1997-12-12 1998-11-20 Combinations of statin and alkylether derivatives
IL15732498A IL157324A0 (en) 1997-12-12 1998-11-20 A synergistic pharmaceutical composition for managing cardiac risk comprising two components
IL15732398A IL157323A0 (en) 1997-12-12 1998-11-20 A synergistic pharmaceutical composition for achieving hypolipidemic effect comprising two components
IL15732598A IL157325A0 (en) 1997-12-12 1998-11-20 A kit comprising a carboxyalkylether and a statin for achieving a therapeutic effect in treatment of hyperlipidemia and cardiac risk

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US6937597P 1997-12-12 1997-12-12
PCT/US1998/024679 WO1999030704A1 (en) 1997-12-12 1998-11-20 Statin-carboxyalkylether combinations

Publications (1)

Publication Number Publication Date
IL135349A0 true IL135349A0 (en) 2001-05-20

Family

ID=22088573

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13534998A IL135349A0 (en) 1997-12-12 1998-11-20 Statin-carboxyalkylether combinations

Country Status (30)

Country Link
EP (1) EP1045691B1 (pt)
JP (1) JP2002508320A (pt)
KR (1) KR20010033003A (pt)
AR (1) AR017851A1 (pt)
AT (1) ATE285762T1 (pt)
AU (1) AU754089B2 (pt)
BR (1) BR9813542A (pt)
CA (1) CA2304612A1 (pt)
CO (1) CO4970816A1 (pt)
CR (1) CR5926A (pt)
CU (1) CU20000140A7 (pt)
DE (1) DE69828442T2 (pt)
DK (1) DK1045691T3 (pt)
ES (1) ES2230733T3 (pt)
GT (1) GT199800196A (pt)
HN (1) HN1998000185A (pt)
HU (1) HUP0004547A3 (pt)
IL (1) IL135349A0 (pt)
IS (1) IS2150B (pt)
MY (1) MY118381A (pt)
NO (1) NO20002966D0 (pt)
NZ (1) NZ503982A (pt)
PA (1) PA8464601A1 (pt)
PE (1) PE20000017A1 (pt)
PL (1) PL341066A1 (pt)
PT (1) PT1045691E (pt)
SV (1) SV1998000146A (pt)
UY (1) UY25299A1 (pt)
WO (1) WO1999030704A1 (pt)
ZA (1) ZA9811348B (pt)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2299397A1 (en) * 1997-12-12 1999-06-24 Warner-Lambert Company Antihyperlipidemic statin-lp(a) inhibitor combinations
US6861555B2 (en) 2000-01-25 2005-03-01 Warner-Lambert Company Calcium dicarboxylate ethers, methods of making same, and treatment of vascular disease and diabetes therewith
US20030105154A1 (en) 2001-10-24 2003-06-05 Bisgaier Charles Larry Statin-carboxyalkylether combinations
SI1117392T1 (en) * 1998-09-30 2004-06-30 Warner-Lambert Company Llc Method for preventing or delaying catheter-based revascularization
US6562864B1 (en) * 1999-09-02 2003-05-13 Drake Larson Catechin multimers as therapeutic drug delivery agents
IN191580B (pt) * 1999-12-17 2003-12-06 Ranbaxy Lab Ltd
DE60138686D1 (de) 2000-01-25 2009-06-25 Warner Lambert Co Calcium-dicarboxylatether, verfahren zu deren herstellung
WO2001078747A1 (de) * 2000-04-18 2001-10-25 Bayer Aktiengesellschaft Verwendung von cse-hemmern zur behandlung von herzinsuffizienz
BR0110234A (pt) * 2000-04-26 2003-03-05 Warner Lambert Co Agentes anti-hipertensivos e uso
US6689807B1 (en) * 2000-06-08 2004-02-10 Caritas St. Elizabeth's Medical Center Of Boston, Inc. HMG CoA reductase inhibitors for promoting angiogenesis
IL160077A0 (en) * 2001-08-16 2004-06-20 Teva Pharma Processes for preparing calcium salt forms of statins
KR20040026705A (ko) 2001-08-16 2004-03-31 테바 파마슈티컬 인더스트리즈 리미티드 스타틴의 칼슘 염 형태의 제조 방법
US20050026979A1 (en) * 2003-07-31 2005-02-03 Maha Ghazzi Methods for treating inflammation and inflammation-associated diseases with a statin and ether
MX367352B (es) * 2012-01-06 2019-08-16 Gemphire Therapeutics Inc Metodos para reducir el riesgo de padecer una enfermedad cardiovascular.
MX2018005540A (es) * 2015-11-06 2018-11-09 Gemphire Therapeutics Inc Tratamiento de dislipemia mixta.

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5648387A (en) * 1995-03-24 1997-07-15 Warner-Lambert Company Carboxyalkylethers, formulations, and treatment of vascular diseases

Also Published As

Publication number Publication date
WO1999030704A1 (en) 1999-06-24
EP1045691A1 (en) 2000-10-25
KR20010033003A (ko) 2001-04-25
GT199800196A (es) 2000-06-03
PE20000017A1 (es) 2000-01-20
AR017851A1 (es) 2001-10-24
ES2230733T3 (es) 2005-05-01
ATE285762T1 (de) 2005-01-15
AU754089B2 (en) 2002-11-07
NZ503982A (en) 2002-03-28
HUP0004547A3 (en) 2001-12-28
JP2002508320A (ja) 2002-03-19
UY25299A1 (es) 2001-08-27
ZA9811348B (en) 1999-06-14
DK1045691T3 (da) 2005-03-14
HN1998000185A (es) 1999-06-02
IS2150B (is) 2006-10-13
HUP0004547A2 (hu) 2001-05-28
PA8464601A1 (es) 2001-12-14
SV1998000146A (es) 1999-09-30
IS5445A (is) 2000-04-14
EP1045691B1 (en) 2004-12-29
BR9813542A (pt) 2000-10-10
PL341066A1 (en) 2001-03-26
CU20000140A7 (es) 2005-10-19
AU1591599A (en) 1999-07-05
DE69828442T2 (de) 2005-06-02
MY118381A (en) 2004-10-30
NO20002966L (no) 2000-06-09
CA2304612A1 (en) 1999-06-24
CR5926A (es) 2000-03-06
DE69828442D1 (de) 2005-02-03
PT1045691E (pt) 2005-03-31
CO4970816A1 (es) 2000-11-07
NO20002966D0 (no) 2000-06-09

Similar Documents

Publication Publication Date Title
EP1022970A4 (en) RUNNING
IL124350A0 (en) Resorcinyl-triazines
IL135349A0 (en) Statin-carboxyalkylether combinations
DE59803148D1 (en) Dimensionsstabile thermoplastische formmassen
DE59708342D1 (en) Basophilen-degranulationstest
GB9702758D0 (en) Floorboxes
ZA982111B (en) Endothelin-receptor-antagonists
GB9713760D0 (en) Movie-sensors
GB2330196B (en) Starcloth
GB9719645D0 (en) AppliquÚs
CA80915S (en) Elbow-rest
CA82748S (en) Handleset
CA82746S (en) Handleset
CA82745S (en) Handleset
CA79884S (en) Moniitor
CA80851S (en) Thermomter
CA80910S (en) Aeroglisseur
CA81694S (en) Tape-rule
SI1045691T1 (en) Statin-carboxyalkylether combinations
GB9706589D0 (en) Autoscore
AU134508S (en) Book-end
GB9712074D0 (en) Besvac
GB9715251D0 (en) Steriloop
GB9701376D0 (en) Camera-boat
GB9715484D0 (en) Ecofin